Related references
Note: Only part of the references are listed.Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting
Lester D. R. Thompson et al.
HUMAN PATHOLOGY (2021)
Dopamine β-hydroxylase: An Essential and Optimal Immunohistochemical Marker for Pheochromocytoma and Sympathetic Paraganglioma
Noriko Kimura
ENDOCRINE PATHOLOGY (2021)
What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?
Thomas G. Papathomas et al.
ENDOCRINE PATHOLOGY (2021)
Metastatic Pheochromocytomas and Abdominal Paragangliomas
Dan Granberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study
Andreas Ebbehoj et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study
Judith Favier et al.
MODERN PATHOLOGY (2020)
The role of CSDE1 in translational reprogramming and human diseases
Ao-Xiang Guo et al.
CELL COMMUNICATION AND SIGNALING (2020)
Pheochromocytoma/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options
Karren Antonio et al.
GLAND SURGERY (2020)
An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma
Alexandre Buffet et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer
Subhadra Kumari et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2020)
TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition
Aurelie Morin et al.
CELL REPORTS (2020)
Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma
Jingjing Jiang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin
Carl Christofer Juhlin et al.
ENDOCRINE PATHOLOGY (2020)
Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors
Divya Mamilla et al.
HUMAN PATHOLOGY (2020)
Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems
Heather Wachtel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma
You Zhou et al.
Aging-US (2020)
Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis
Joakim Crona et al.
ENDOCRINE-RELATED CANCER (2019)
COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas
Charlie Pierre et al.
VIRCHOWS ARCHIV (2019)
The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the Literature
Adam Stenman et al.
CANCERS (2019)
Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up
Adam Stenman et al.
SURGERY (2019)
Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior
Adam Stenman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma
Sylvie Job et al.
CLINICAL CANCER RESEARCH (2019)
Presentation, Treatment, Histology, and Outcomes in Adrenal Medullary Hyperplasia Compared With Pheochromocytoma
Henrik Falhammar et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
TERT structural rearrangements in metastatic pheochromocytomas
Trisha Dwight et al.
ENDOCRINE-RELATED CANCER (2018)
Initial clinical presentation and spectrum of pheochromocytoma: a study of 94 cases from a single center
Henrik Falhammar et al.
ENDOCRINE CONNECTIONS (2018)
Chromaffin cell biology: inferences from The Cancer Genome Atlas
Lauren Fishbein et al.
CELL AND TISSUE RESEARCH (2018)
TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours
Johan O. Paulsson et al.
ENDOCRINE-RELATED CANCER (2018)
The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes
Aaron M. Udager et al.
HUMAN PATHOLOGY (2018)
Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms
Adam Stenman et al.
LANGENBECKS ARCHIVES OF SURGERY (2018)
Current diagnostic imaging of pheochromocytomas and implications for therapeutic strategy
Filip Ctvrtlik et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Pheochromocytoma: When to search a germline defect?
Alexandre Buffet et al.
PRESSE MEDICALE (2018)
The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations
Sylvia L. Asa et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation
Pauline Romanet et al.
ENDOCRINE PATHOLOGY (2017)
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas
Rodrigo A. Toledo et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Joakim Crona et al.
ENDOCRINE REVIEWS (2017)
Utility of GATA3 in the differential diagnosis of pheochromocytoma
Carmen M. Perrino et al.
HISTOPATHOLOGY (2017)
A post-transcriptional program coordinated by CSDE1 prevents intrinsic neural differentiation of human embryonic stem cells
Hyun Ju Lee et al.
NATURE COMMUNICATIONS (2017)
Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma
Jung-Min Koh et al.
PLOS ONE (2017)
Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations
Samuel Backman et al.
SCIENTIFIC REPORTS (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas
Rodrigo A. Toledo et al.
CLINICAL CANCER RESEARCH (2016)
Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes
Annica Wilzen et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas
Katja Specht et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Complex MAX Rearrangement in a Family With Malignant Pheochromocytoma, Renal Oncocytoma, and Erythrocytosis
Esther Korpershoek et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Risk Stratification in Paragangliomas with PASS (Pheochromocytoma of the Adrenal Gland Scaled Score) and Immunohistochemical Markers
Maithili Mandar Kulkarni et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2016)
Structural and functional consequences of succinate dehydrogenase subunit B mutations
E. Kim et al.
ENDOCRINE-RELATED CANCER (2015)
Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene
C. Christofer Juhlin et al.
GENES CHROMOSOMES & CANCER (2015)
SDHD Immunohistochemistry: A New Tool to Validate SDHx Mutations in Pheochromocytoma/Paraganglioma
Melanie Menara et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients
Maria Curras-Freixes et al.
JOURNAL OF MEDICAL GENETICS (2015)
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)
Thomas G. Papathomas et al.
MODERN PATHOLOGY (2015)
Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas
Luis Jaime Castro-Vega et al.
NATURE COMMUNICATIONS (2015)
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors
Attje S. Hoekstra et al.
ONCOTARGET (2015)
Immunohistochemical NF1 Analysis Does not Predict NF1 Gene Mutation Status in Pheochromocytoma
Adam Stenman et al.
ENDOCRINE PATHOLOGY (2015)
Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia
Chunzhang Yang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
Judith Favier et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
Tiantian Liu et al.
ENDOCRINE-RELATED CANCER (2014)
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma
Noriko Kimura et al.
ENDOCRINE-RELATED CANCER (2014)
Succinate-to-Fumarate Ratio as a New Metabolic Marker to Detect the Presence of SDHB/D-related Paraganglioma: Initial Experimental and Ex Vivo Findings
Nikoletta Lendvai et al.
ENDOCRINOLOGY (2014)
Biochemical diagnosis of phaeochromocytoma and paraganglioma
A. van Berkel et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
Julien Hadoux et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
H-RAS Mutations Are Restricted to Sporadic Pheochromocytomas Lacking Specific Clinical or Pathological Features: Data From a Multi-Institutional Series
Lindsey Oudijk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency
Susan Richter et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Rare Germline Mutations Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma
Jenny Welander et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma
Xiaoke Wang et al.
NATURE GENETICS (2014)
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
Eric Letouze et al.
CANCER CELL (2013)
Usefulness of Negative and Weak-Diffuse Pattern of SDHB Immunostaining in Assessment of SDH Mutations in Paragangliomas and Pheochromocytomas
Esmeralda Castelblanco et al.
ENDOCRINE PATHOLOGY (2013)
Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation
Nimrod B. Kiss et al.
ENDOCRINE-RELATED CANCER (2013)
In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas
Rodrigo A. Toledo et al.
ENDOCRINE-RELATED CANCER (2013)
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis
Inaki Comino-Mendez et al.
HUMAN MOLECULAR GENETICS (2013)
Somatic Mutations in H-RAS in Sporadic Pheochromocytoma and Paraganglioma Identified by Exome Sequencing
Joakim Crona et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Imaging Work-Up for Screening of Paraganglioma and Pheochromocytoma in SDHx Mutation Carriers: A Multicenter Prospective Study from the PGL.EVA Investigators
Anne-Paule Gimenez-Roqueplo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma
Felipe R. Lorenzo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
NEUROENDOCRINE MARKERS AND SUSTENTACULAR CELL COUNT IN BENIGN AND MALIGNANT PHEOCHROMOCYTOMAS - A COMPARATIVE STUDY
Magdalena Bialas et al.
POLISH JOURNAL OF PATHOLOGY (2013)
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
Mengtao Xiao et al.
GENES & DEVELOPMENT (2012)
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2012)
Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia
Anthony J. Gill
PATHOLOGY (2012)
Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo
Toshinao Oyama et al.
DEVELOPMENT (2011)
Overexpression of the natural antisense hypoxia-inducible factor-1α transcript is associated with malignant pheochromocytoma/paraganglioma
P. N. Span et al.
ENDOCRINE-RELATED CANCER (2011)
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2011)
SDHA Immunohistochemistry Detects Germline SDHA Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas
Esther Korpershoek et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
Inaki Comino-Mendez et al.
NATURE GENETICS (2011)
Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center
Auryan Szalat et al.
ENDOCRINE (2011)
SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling
Annika Blank et al.
ENDOCRINE-RELATED CANCER (2010)
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes
Anthony J. Gill et al.
HUMAN PATHOLOGY (2010)
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
Yuejuan Qin et al.
NATURE GENETICS (2010)
Size of the Tumor and Pheochromocytoma of the Adrenal Gland Scaled Score (PASS): Can They Predict Malignancy?
Amit Agarwal et al.
WORLD JOURNAL OF SURGERY (2010)
Observer Variation in the Application of the Pheochromocytoma of the Adrenal Gland Scaled Score
David Wu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
Francien H. van Nederveen et al.
LANCET ONCOLOGY (2009)
Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas:: Association to malignant behavior
Janos Geli et al.
CLINICAL CANCER RESEARCH (2008)
The kinesin KIF1B beta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
Susanne Schlisio et al.
GENES & DEVELOPMENT (2008)
Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis
Vivian E. Strong et al.
SURGERY (2008)
Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma
Emily H. Smith et al.
HUMAN MOLECULAR GENETICS (2007)
Needle biopsy of incidentally discovered adrenal masses is rarely informative and potentially hazardous
Frank J. Quayle et al.
SURGERY (2007)
Expression of HIF-1α, HIF-2α (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations
Patrick J. Pollard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas
Baohua Gao et al.
UROLOGY (2006)
Genetic aberrance of sporadic MEN 2A component tumours: analysis of RET
NH Cho et al.
PATHOLOGY (2005)
CGH and C 44/MIB-1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas
C August et al.
MODERN PATHOLOGY (2004)
Ki-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma
EE Elder et al.
MODERN PATHOLOGY (2003)
Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms - A clinicopathologic and immunophenotypic study of 100 cases
LDR Thompson
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
IPM Tomlinson et al.
NATURE GENETICS (2002)
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma
D Astuti et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
